Analysts Anticipate Horizon Therapeutics Public Limited (NASDAQ:HZNP) Will Announce Quarterly Sales of $868.41 Million
Equities research analysts expect that Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) will post sales of $868.41 million for the current quarter, Zacks reports. Four analysts have provided estimates for Horizon Therapeutics Public’s earnings, with the highest sales estimate coming in at $883.55 million and the lowest estimate coming in at $846.97 million. Horizon […]